文献速递消化内镜消化道肿瘤与早癌

T1结直肠癌内镜黏膜下剥离术后长期结局:多中心前瞻性研究

Long-Term Outcomes After Endoscopic Submucosal Dissection for T1 Colorectal Cancer: A Multicenter Prospective Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-03-19

这项由广岛GI内镜研究组开展的大规模多中心前瞻性队列研究,纳入2014至2018年病理确诊T1结直肠癌并接受ESD的383例患者,按日本结直肠癌研究指南分为低危和高危组。低危组无复发和死亡;高危组中随访组5年局部复发率显著高于手术组(6.8% vs 0%,P<.001),但远处复发和疾病特异性生存无显著差异。

要点

  • 低危T1结直肠癌单纯ESD后无复发和疾病特异性死亡,无需强化监测。
  • 高危T1结直肠癌追加手术可降低局部复发,但对远处转移和疾病特异性生存影响不明确。
  • 高危组随访组5年总生存显著劣于手术组(79.7% vs 95.2%,P<.001)。

核心结论

  • 低危T1结直肠癌单纯ESD后无复发或疾病特异性死亡,提示无需强化监测。
  • 高危T1结直肠癌追加手术可预防局部复发,但对远处转移和疾病特异性生存的影响尚不明确。

研究设计与样本

  • 由广岛GI内镜研究组开展的大规模多中心前瞻性队列研究。
  • 纳入2014至2018年病理确诊T1结直肠癌并接受结直肠ESD的连续患者383例。
  • 按日本结直肠癌研究指南分为低危和高危组,高危组再分为追加手术组和随访组。
  • 主要结局为5年累积复发率。

主要发现

  • 高危组5年累积局部复发率随访组显著高于手术组(6.8% vs 0%,P<.001)。
  • 高危组5年远处复发率随访组与手术组无显著差异(2.7% vs 1.9%,P=.704)。
  • 高危组5年总生存随访组显著劣于手术组(79.7% vs 95.2%,P<.001)。
  • 高危组5年疾病特异性生存随访组与手术组相似(98.4% vs 98.5%,P=.420)。

关键数值与推荐

  • 低危和高危分层依据日本结直肠癌研究指南。
  • 高危组5年累积局部复发率随访组6.8% vs 手术组0%(P<.001)。
  • 高危组5年远处复发率随访组2.7% vs 手术组1.9%(P=.704)。
  • 高危组5年总生存随访组79.7% vs 手术组95.2%(P<.001)。
  • 高危组5年疾病特异性生存随访组98.4% vs 手术组98.5%(P=.420)。

临床怎么用

  • 低危T1结直肠癌经治愈性ESD后可考虑单纯随访,无需强化监测。
  • 高危T1结直肠癌追加手术可能降低局部复发,但需权衡对远处转移和疾病特异性生存的不明确影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Prospective evidence for the long-term efficacy of endoscopic submucosal dissection (ESD) for T1 colorectal cancer (CRC) is lacking. We evaluated the long-term outcomes after ESD for T1 CRC, focusing on risk stratification and the benefits of additional surgery. METHODS: This large-scale, multicenter, prospective cohort study, conducted by Hiroshima GI Endoscopy Research Group, included consecutive patients with pathologically confirmed T1 CRC who underwent colorectal ESD between 2014 and 2018. Patients were classified into low- and high-risk groups per Japanese Society for Colorectal Cancer Research guidelines. High-risk patients either underwent additional surgery (surgery group) or were followed without surgery (follow-up group). The primary outcome was the 5-year cumulative recurrence rate. RESULTS: Among 2358 patients who underwent ESD for 2478 early colorectal neoplasms, 383 patients with T1 CRC were enrolled. Ten recurrences (3.6%) and 5 T1 CRC-associated deaths (1.8%) occurred in the high-risk group; none occurred in the low-risk group. Five-year cumulative local recurrence rate in the high-risk group was significantly higher in the follow-up group than in the surgery group (6.8% vs 0%; P < .001), whereas distant recurrence did not differ significantly (2.7% vs 1.9%; P = .704). Five-year overall survival in the high-risk group was significantly worse in the follow-up group than in the surgery group (79.7% vs 95.2%; P < .001), whereas 5-year disease-specific survival was similar (98.4% vs 98.5%; P = .420). CONCLUSIONS: ESD alone appears appropriate for low-risk T1 CRC, with no recurrence or disease-specific mortality observed, suggesting that intensive surveillance is unnecessary after curative ESD. In high-risk T1 CRC, additional surgery could prevent local recurrence; however, its impact on distant metastasis and disease-specific survival remains unclear. TRIAL REGISTRATION NUMBER: UMIN000016197.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Hamada T, Kuwai T, Kamigaichi Y, et al. Long-Term Outcomes After Endoscopic Submucosal Dissection for T1 Colorectal Cancer: A Multicenter Prospective Study. Clin Gastroenterol Hepatol. 2026. PMID: 41861934. doi:10.1016/j.cgh.2026.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。